학술논문
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
Document Type
Article
Author
Camidge, D Ross; Bang, Yung-Jue; Kwak, Eunice L; Iafrate, A John; Varella-Garcia, Marileila; Fox, Stephen B; Riely, Gregory J; Solomon, Benjamin; Ou, Sai-Hong I; Kim, Dong-Wan; Salgia, Ravi; Fidias, Panagiotis; Engelman, Jeffrey A; Gandhi, Leena; Jänne, Pasi A; Costa, Daniel B; Shapiro, Geoffrey I; LoRusso, Patricia; Ruffner, Katherine; Stephenson, Patricia; Tang, Yiyun; Wilner, Keith; Clark, Jeffrey W; Shaw, Alice T
Source
In Lancet Oncology October 2012 13(10):1011-1019
Subject
Language
ISSN
1470-2045